Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 31, 2008

Impax Sued Based on Anda For Generic Doryx

Dec 15, 2008

Robert L. Burr Elected Chairman of the Board of Directors of IMPAX Laboratories, Inc.

Dec 11, 2008

Impax Provides Update On Meeting With FDA To Review Phase III Trial Results For IPX056

Dec 09, 2008

Impax’s Registration Statement on Form 10 Becomes Effective

Dec 08, 2008

Amneal Receives FDA Approval For Over-The-Counter Strength Naproxen Sodium Tablets & Caplets, USP

Dec 03, 2008

IMPAX Files Amended Form 10/A Registration Statement

Dec 01, 2008

Medicis and IMPAX Announce R&D Collaboration and Settlement

Nov 28, 2008

Impax Receives Final Fda Approval For Generic Wellbutrin® Xl 150 Mg

Nov 18, 2008

Impax Sued Based on Anda for Generic Cymbalta®

Nov 14, 2008

Impax To Webcast Presentation To Analysts On November 17, 2008

Oct 10, 2008

Impax Files Form 10 Registration Statement

Sep 18, 2008

IMPAX To Present At UBS 2008 Global Life Sciences Conference

Sep 15, 2008

IMPAX Mourns The Death Of Dr. Charles Hsiao, Co-Founder And Chairman

Sep 08, 2008

Amneal Receives FDA Approval For Its First Liquid Rx Product, Ranitidine Hydrochloride Syrup

Aug 13, 2008

IMPAX Sued Based on ANDA for Generic Ultram® ER

Aug 07, 2008

IMPAX Reports Positive Results in Phase III Trial with IPX056

Jul 31, 2008

Impax to Present at Bank Of America Specialty Pharmaceuticals Conference

Jul 28, 2008

Impax Sued Based On Anda Amendment For Additional Dosage Forms Of Generic OPANA® ER

Jul 22, 2008

IMPAX Sued Based on ANDA for Generic Flomax ®

Jul 16, 2008

IMPAX Announces Final Settlement Of Generic EFFEXOR XR Patent Suit

Jun 28, 2008

Amneal Closes Purchase of Interpharm Assets

Jun 27, 2008

IMPAX Updates the Filing Status of Its Registration Statement

May 28, 2008

IMPAX Cancels Scheduled Presentation at UBS Global Specialty Generic Pharmaceuticals Conference

May 27, 2008

IMPAX Reports on SEC Order Revoking Common Stock Registration and Progress in Obtaining Re-Registration

May 23, 2008

IMPAX to Present at UBS Global Specialty and Generic Pharmaceuticals Conference

May 15, 2008

IMPAX to Present at Citi Investment Research 2008 Global Healthcare Conference

May 08, 2008

IMPAX to Present at Bank of America's 2008 Healthcare Conference

May 07, 2008

Amneal Receives FDA Approval Using New Electronic Filing Format

May 02, 2008

IMPAX Continues to Make Progress in Filing Delinquent Periodic Reports

Apr 24, 2008

Amneal to Acquire Assets of Interpharm Holdings

Apr 17, 2008

IMPAX Reports FDA Finding That Budeprion XL(R) 300 mg Is Safe and Effective

Apr 14, 2008

IMPAX to Develop Next-Generation Carbidopa/Levodopa Product

Mar 31, 2008

Demeclocycline HCl Tabs Approved

Mar 31, 2008

IMPAX Establishes Branded Products Division with Appointments of Senior Management

Mar 11, 2008

IMPAX To Present at Upcoming Investment Conferences

Mar 07, 2008

Primidone Tabs Approved

Mar 06, 2008

IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA(R)

Mar 01, 2008

Cyclobenzaprine HCl Tabs Approved

Feb 27, 2008

IMPAX to Present Oral Argument in SEC Proceeding on May 5th

Feb 01, 2008

IMPAX to Present at Merrill Lynch's Global Pharmaceutical, Biotechnology and Medical Device Conference

Jan 30, 2008

IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options

Jan 15, 2008

IMPAX Announces Lawsuit Related to Generic Version of SOLODYN(R)

Jan 03, 2008

IMPAX to Present at JP Morgan's 26th Annual Healthcare Conference

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14